Lv1
50 积分 2026-05-08 加入
Liver-targeting chimeras as a potential modality for the treatment of liver diseases
3个月前
已完结
Targeted Degradation of Lin28B Using Pre-let-7-PROTACs for Hepatocellular Carcinoma Therapy
3个月前
已完结
Advances in cancer immunotherapy using small-molecular inhibitors targeting the PD-1/PD-L1 interaction
3个月前
已完结
Multispecific Antibodies Targeting PD-1/PD-L1 in Cancer
3个月前
已完结
Discovery of bromobenzyl phenyl ether derivative YPD-29B: a novel pre-clinical compound targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction
3个月前
已完结
An Update on Patent issues regarding Antibody Drug Conjugates
3个月前
已完结
Simple Structural Modifications Converting a Bona fide MDM2 PROTAC Degrader into a Molecular Glue Molecule: A Cautionary Tale in the Design of PROTAC Degraders
4个月前
已完结
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
4个月前
已完结
Exploring the next generation of antibody–drug conjugates
4个月前
已完结
Discovery of Selective and Potent ATR Degrader for Exploration its Kinase‐Independent Functions in Acute Myeloid Leukemia Cells
4个月前
已完结
皖公网安备34019202002308
